Global VEGFA Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 02 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global VEGFA Antibody market size was valued at USD 406 million in 2022 and is forecast to a readjusted size of USD 890.1 million by 2029 with a CAGR of 11.9% during review period.

VEGFA Antibody is an antibody specific for vascular endothelial growth factor A (VEGFA) protein.

VEGFA is an important cytokine that plays a key role in processes such as angiogenesis, vascular permeability and angiogenesis. It regulates the growth and development of the vascular system by binding to VEGF receptors, and has an important impact on the maintenance of normal physiological status and the development of disease status. The application of VEGFA antibody can be used to detect and analyze the expression level and localization of VEGFA protein in research, especially in the fields of oncology, ophthalmic diseases and cardiovascular diseases. In addition, VEGFA antibody may also be used as a potential strategy for anti-tumor therapy and angiogenesis inhibitory therapy, providing useful information for the treatment and drug development of related diseases.

The Global Info Research report includes an overview of the development of the VEGFA Antibody industry chain, the market status of Flow Cytometry (Monoclonal Antibody, Polyclonal Antibody), ELISA (Monoclonal Antibody, Polyclonal Antibody), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of VEGFA Antibody.

Regionally, the report analyzes the VEGFA Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global VEGFA Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the VEGFA Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the VEGFA Antibody industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibody, Polyclonal Antibody).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the VEGFA Antibody market.

Regional Analysis: The report involves examining the VEGFA Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the VEGFA Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to VEGFA Antibody:
Company Analysis: Report covers individual VEGFA Antibody manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards VEGFA Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Flow Cytometry, ELISA).

Technology Analysis: Report covers specific technologies relevant to VEGFA Antibody. It assesses the current state, advancements, and potential future developments in VEGFA Antibody areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the VEGFA Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
VEGFA Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Monoclonal Antibody
Polyclonal Antibody

Market segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others

Major players covered
Sino Biological, Inc.
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
BioLegend
LifeSpan BioSciences, Inc
Elabscience Biotechnology Inc.
Boster Biological Technology
Merck
Wuhan Fine Biotech Co., Ltd.
ProSci Incorporated
Abbexa
Miltenyi Biotec
Arigo Biolaboratories Corp.
Assay Genie

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe VEGFA Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of VEGFA Antibody, with price, sales, revenue and global market share of VEGFA Antibody from 2018 to 2023.
Chapter 3, the VEGFA Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the VEGFA Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and VEGFA Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of VEGFA Antibody.
Chapter 14 and 15, to describe VEGFA Antibody sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of VEGFA Antibody
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global VEGFA Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Monoclonal Antibody
        1.3.3 Polyclonal Antibody
    1.4 Market Analysis by Application
        1.4.1 Overview: Global VEGFA Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Flow Cytometry
        1.4.3 ELISA
        1.4.4 Western Blot
        1.4.5 Immunoprecipitation
        1.4.6 Immunofluorescence
        1.4.7 Others
    1.5 Global VEGFA Antibody Market Size & Forecast
        1.5.1 Global VEGFA Antibody Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global VEGFA Antibody Sales Quantity (2018-2029)
        1.5.3 Global VEGFA Antibody Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sino Biological, Inc.
        2.1.1 Sino Biological, Inc. Details
        2.1.2 Sino Biological, Inc. Major Business
        2.1.3 Sino Biological, Inc. VEGFA Antibody Product and Services
        2.1.4 Sino Biological, Inc. VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sino Biological, Inc. Recent Developments/Updates
    2.2 Abcam
        2.2.1 Abcam Details
        2.2.2 Abcam Major Business
        2.2.3 Abcam VEGFA Antibody Product and Services
        2.2.4 Abcam VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Abcam Recent Developments/Updates
    2.3 Thermo Fisher Scientific (China) Co., Ltd.
        2.3.1 Thermo Fisher Scientific (China) Co., Ltd. Details
        2.3.2 Thermo Fisher Scientific (China) Co., Ltd. Major Business
        2.3.3 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product and Services
        2.3.4 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
    2.4 Bio-Techne
        2.4.1 Bio-Techne Details
        2.4.2 Bio-Techne Major Business
        2.4.3 Bio-Techne VEGFA Antibody Product and Services
        2.4.4 Bio-Techne VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bio-Techne Recent Developments/Updates
    2.5 BioLegend
        2.5.1 BioLegend Details
        2.5.2 BioLegend Major Business
        2.5.3 BioLegend VEGFA Antibody Product and Services
        2.5.4 BioLegend VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 BioLegend Recent Developments/Updates
    2.6 LifeSpan BioSciences, Inc
        2.6.1 LifeSpan BioSciences, Inc Details
        2.6.2 LifeSpan BioSciences, Inc Major Business
        2.6.3 LifeSpan BioSciences, Inc VEGFA Antibody Product and Services
        2.6.4 LifeSpan BioSciences, Inc VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
    2.7 Elabscience Biotechnology Inc.
        2.7.1 Elabscience Biotechnology Inc. Details
        2.7.2 Elabscience Biotechnology Inc. Major Business
        2.7.3 Elabscience Biotechnology Inc. VEGFA Antibody Product and Services
        2.7.4 Elabscience Biotechnology Inc. VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Elabscience Biotechnology Inc. Recent Developments/Updates
    2.8 Boster Biological Technology
        2.8.1 Boster Biological Technology Details
        2.8.2 Boster Biological Technology Major Business
        2.8.3 Boster Biological Technology VEGFA Antibody Product and Services
        2.8.4 Boster Biological Technology VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Boster Biological Technology Recent Developments/Updates
    2.9 Merck
        2.9.1 Merck Details
        2.9.2 Merck Major Business
        2.9.3 Merck VEGFA Antibody Product and Services
        2.9.4 Merck VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Merck Recent Developments/Updates
    2.10 Wuhan Fine Biotech Co., Ltd.
        2.10.1 Wuhan Fine Biotech Co., Ltd. Details
        2.10.2 Wuhan Fine Biotech Co., Ltd. Major Business
        2.10.3 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product and Services
        2.10.4 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
    2.11 ProSci Incorporated
        2.11.1 ProSci Incorporated Details
        2.11.2 ProSci Incorporated Major Business
        2.11.3 ProSci Incorporated VEGFA Antibody Product and Services
        2.11.4 ProSci Incorporated VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 ProSci Incorporated Recent Developments/Updates
    2.12 Abbexa
        2.12.1 Abbexa Details
        2.12.2 Abbexa Major Business
        2.12.3 Abbexa VEGFA Antibody Product and Services
        2.12.4 Abbexa VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Abbexa Recent Developments/Updates
    2.13 Miltenyi Biotec
        2.13.1 Miltenyi Biotec Details
        2.13.2 Miltenyi Biotec Major Business
        2.13.3 Miltenyi Biotec VEGFA Antibody Product and Services
        2.13.4 Miltenyi Biotec VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Miltenyi Biotec Recent Developments/Updates
    2.14 Arigo Biolaboratories Corp.
        2.14.1 Arigo Biolaboratories Corp. Details
        2.14.2 Arigo Biolaboratories Corp. Major Business
        2.14.3 Arigo Biolaboratories Corp. VEGFA Antibody Product and Services
        2.14.4 Arigo Biolaboratories Corp. VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Arigo Biolaboratories Corp. Recent Developments/Updates
    2.15 Assay Genie
        2.15.1 Assay Genie Details
        2.15.2 Assay Genie Major Business
        2.15.3 Assay Genie VEGFA Antibody Product and Services
        2.15.4 Assay Genie VEGFA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Assay Genie Recent Developments/Updates

3 Competitive Environment: VEGFA Antibody by Manufacturer
    3.1 Global VEGFA Antibody Sales Quantity by Manufacturer (2018-2023)
    3.2 Global VEGFA Antibody Revenue by Manufacturer (2018-2023)
    3.3 Global VEGFA Antibody Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of VEGFA Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 VEGFA Antibody Manufacturer Market Share in 2022
        3.4.2 Top 6 VEGFA Antibody Manufacturer Market Share in 2022
    3.5 VEGFA Antibody Market: Overall Company Footprint Analysis
        3.5.1 VEGFA Antibody Market: Region Footprint
        3.5.2 VEGFA Antibody Market: Company Product Type Footprint
        3.5.3 VEGFA Antibody Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global VEGFA Antibody Market Size by Region
        4.1.1 Global VEGFA Antibody Sales Quantity by Region (2018-2029)
        4.1.2 Global VEGFA Antibody Consumption Value by Region (2018-2029)
        4.1.3 Global VEGFA Antibody Average Price by Region (2018-2029)
    4.2 North America VEGFA Antibody Consumption Value (2018-2029)
    4.3 Europe VEGFA Antibody Consumption Value (2018-2029)
    4.4 Asia-Pacific VEGFA Antibody Consumption Value (2018-2029)
    4.5 South America VEGFA Antibody Consumption Value (2018-2029)
    4.6 Middle East and Africa VEGFA Antibody Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global VEGFA Antibody Sales Quantity by Type (2018-2029)
    5.2 Global VEGFA Antibody Consumption Value by Type (2018-2029)
    5.3 Global VEGFA Antibody Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global VEGFA Antibody Sales Quantity by Application (2018-2029)
    6.2 Global VEGFA Antibody Consumption Value by Application (2018-2029)
    6.3 Global VEGFA Antibody Average Price by Application (2018-2029)

7 North America
    7.1 North America VEGFA Antibody Sales Quantity by Type (2018-2029)
    7.2 North America VEGFA Antibody Sales Quantity by Application (2018-2029)
    7.3 North America VEGFA Antibody Market Size by Country
        7.3.1 North America VEGFA Antibody Sales Quantity by Country (2018-2029)
        7.3.2 North America VEGFA Antibody Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe VEGFA Antibody Sales Quantity by Type (2018-2029)
    8.2 Europe VEGFA Antibody Sales Quantity by Application (2018-2029)
    8.3 Europe VEGFA Antibody Market Size by Country
        8.3.1 Europe VEGFA Antibody Sales Quantity by Country (2018-2029)
        8.3.2 Europe VEGFA Antibody Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific VEGFA Antibody Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific VEGFA Antibody Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific VEGFA Antibody Market Size by Region
        9.3.1 Asia-Pacific VEGFA Antibody Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific VEGFA Antibody Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America VEGFA Antibody Sales Quantity by Type (2018-2029)
    10.2 South America VEGFA Antibody Sales Quantity by Application (2018-2029)
    10.3 South America VEGFA Antibody Market Size by Country
        10.3.1 South America VEGFA Antibody Sales Quantity by Country (2018-2029)
        10.3.2 South America VEGFA Antibody Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa VEGFA Antibody Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa VEGFA Antibody Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa VEGFA Antibody Market Size by Country
        11.3.1 Middle East & Africa VEGFA Antibody Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa VEGFA Antibody Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 VEGFA Antibody Market Drivers
    12.2 VEGFA Antibody Market Restraints
    12.3 VEGFA Antibody Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of VEGFA Antibody and Key Manufacturers
    13.2 Manufacturing Costs Percentage of VEGFA Antibody
    13.3 VEGFA Antibody Production Process
    13.4 VEGFA Antibody Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 VEGFA Antibody Typical Distributors
    14.3 VEGFA Antibody Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global VEGFA Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global VEGFA Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
    Table 4. Sino Biological, Inc. Major Business
    Table 5. Sino Biological, Inc. VEGFA Antibody Product and Services
    Table 6. Sino Biological, Inc. VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sino Biological, Inc. Recent Developments/Updates
    Table 8. Abcam Basic Information, Manufacturing Base and Competitors
    Table 9. Abcam Major Business
    Table 10. Abcam VEGFA Antibody Product and Services
    Table 11. Abcam VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Abcam Recent Developments/Updates
    Table 13. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 14. Thermo Fisher Scientific (China) Co., Ltd. Major Business
    Table 15. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product and Services
    Table 16. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments/Updates
    Table 18. Bio-Techne Basic Information, Manufacturing Base and Competitors
    Table 19. Bio-Techne Major Business
    Table 20. Bio-Techne VEGFA Antibody Product and Services
    Table 21. Bio-Techne VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Bio-Techne Recent Developments/Updates
    Table 23. BioLegend Basic Information, Manufacturing Base and Competitors
    Table 24. BioLegend Major Business
    Table 25. BioLegend VEGFA Antibody Product and Services
    Table 26. BioLegend VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. BioLegend Recent Developments/Updates
    Table 28. LifeSpan BioSciences, Inc Basic Information, Manufacturing Base and Competitors
    Table 29. LifeSpan BioSciences, Inc Major Business
    Table 30. LifeSpan BioSciences, Inc VEGFA Antibody Product and Services
    Table 31. LifeSpan BioSciences, Inc VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. LifeSpan BioSciences, Inc Recent Developments/Updates
    Table 33. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
    Table 34. Elabscience Biotechnology Inc. Major Business
    Table 35. Elabscience Biotechnology Inc. VEGFA Antibody Product and Services
    Table 36. Elabscience Biotechnology Inc. VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Elabscience Biotechnology Inc. Recent Developments/Updates
    Table 38. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
    Table 39. Boster Biological Technology Major Business
    Table 40. Boster Biological Technology VEGFA Antibody Product and Services
    Table 41. Boster Biological Technology VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Boster Biological Technology Recent Developments/Updates
    Table 43. Merck Basic Information, Manufacturing Base and Competitors
    Table 44. Merck Major Business
    Table 45. Merck VEGFA Antibody Product and Services
    Table 46. Merck VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Merck Recent Developments/Updates
    Table 48. Wuhan Fine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. Wuhan Fine Biotech Co., Ltd. Major Business
    Table 50. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product and Services
    Table 51. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
    Table 53. ProSci Incorporated Basic Information, Manufacturing Base and Competitors
    Table 54. ProSci Incorporated Major Business
    Table 55. ProSci Incorporated VEGFA Antibody Product and Services
    Table 56. ProSci Incorporated VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. ProSci Incorporated Recent Developments/Updates
    Table 58. Abbexa Basic Information, Manufacturing Base and Competitors
    Table 59. Abbexa Major Business
    Table 60. Abbexa VEGFA Antibody Product and Services
    Table 61. Abbexa VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Abbexa Recent Developments/Updates
    Table 63. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
    Table 64. Miltenyi Biotec Major Business
    Table 65. Miltenyi Biotec VEGFA Antibody Product and Services
    Table 66. Miltenyi Biotec VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Miltenyi Biotec Recent Developments/Updates
    Table 68. Arigo Biolaboratories Corp. Basic Information, Manufacturing Base and Competitors
    Table 69. Arigo Biolaboratories Corp. Major Business
    Table 70. Arigo Biolaboratories Corp. VEGFA Antibody Product and Services
    Table 71. Arigo Biolaboratories Corp. VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Arigo Biolaboratories Corp. Recent Developments/Updates
    Table 73. Assay Genie Basic Information, Manufacturing Base and Competitors
    Table 74. Assay Genie Major Business
    Table 75. Assay Genie VEGFA Antibody Product and Services
    Table 76. Assay Genie VEGFA Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Assay Genie Recent Developments/Updates
    Table 78. Global VEGFA Antibody Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 79. Global VEGFA Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 80. Global VEGFA Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 81. Market Position of Manufacturers in VEGFA Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 82. Head Office and VEGFA Antibody Production Site of Key Manufacturer
    Table 83. VEGFA Antibody Market: Company Product Type Footprint
    Table 84. VEGFA Antibody Market: Company Product Application Footprint
    Table 85. VEGFA Antibody New Market Entrants and Barriers to Market Entry
    Table 86. VEGFA Antibody Mergers, Acquisition, Agreements, and Collaborations
    Table 87. Global VEGFA Antibody Sales Quantity by Region (2018-2023) & (K Units)
    Table 88. Global VEGFA Antibody Sales Quantity by Region (2024-2029) & (K Units)
    Table 89. Global VEGFA Antibody Consumption Value by Region (2018-2023) & (USD Million)
    Table 90. Global VEGFA Antibody Consumption Value by Region (2024-2029) & (USD Million)
    Table 91. Global VEGFA Antibody Average Price by Region (2018-2023) & (US$/Unit)
    Table 92. Global VEGFA Antibody Average Price by Region (2024-2029) & (US$/Unit)
    Table 93. Global VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 94. Global VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 95. Global VEGFA Antibody Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Global VEGFA Antibody Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Global VEGFA Antibody Average Price by Type (2018-2023) & (US$/Unit)
    Table 98. Global VEGFA Antibody Average Price by Type (2024-2029) & (US$/Unit)
    Table 99. Global VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 100. Global VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 101. Global VEGFA Antibody Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. Global VEGFA Antibody Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. Global VEGFA Antibody Average Price by Application (2018-2023) & (US$/Unit)
    Table 104. Global VEGFA Antibody Average Price by Application (2024-2029) & (US$/Unit)
    Table 105. North America VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 106. North America VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 107. North America VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 108. North America VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 109. North America VEGFA Antibody Sales Quantity by Country (2018-2023) & (K Units)
    Table 110. North America VEGFA Antibody Sales Quantity by Country (2024-2029) & (K Units)
    Table 111. North America VEGFA Antibody Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. North America VEGFA Antibody Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Europe VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 114. Europe VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 115. Europe VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 116. Europe VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 117. Europe VEGFA Antibody Sales Quantity by Country (2018-2023) & (K Units)
    Table 118. Europe VEGFA Antibody Sales Quantity by Country (2024-2029) & (K Units)
    Table 119. Europe VEGFA Antibody Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe VEGFA Antibody Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 122. Asia-Pacific VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 123. Asia-Pacific VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 124. Asia-Pacific VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 125. Asia-Pacific VEGFA Antibody Sales Quantity by Region (2018-2023) & (K Units)
    Table 126. Asia-Pacific VEGFA Antibody Sales Quantity by Region (2024-2029) & (K Units)
    Table 127. Asia-Pacific VEGFA Antibody Consumption Value by Region (2018-2023) & (USD Million)
    Table 128. Asia-Pacific VEGFA Antibody Consumption Value by Region (2024-2029) & (USD Million)
    Table 129. South America VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 130. South America VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 131. South America VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 132. South America VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 133. South America VEGFA Antibody Sales Quantity by Country (2018-2023) & (K Units)
    Table 134. South America VEGFA Antibody Sales Quantity by Country (2024-2029) & (K Units)
    Table 135. South America VEGFA Antibody Consumption Value by Country (2018-2023) & (USD Million)
    Table 136. South America VEGFA Antibody Consumption Value by Country (2024-2029) & (USD Million)
    Table 137. Middle East & Africa VEGFA Antibody Sales Quantity by Type (2018-2023) & (K Units)
    Table 138. Middle East & Africa VEGFA Antibody Sales Quantity by Type (2024-2029) & (K Units)
    Table 139. Middle East & Africa VEGFA Antibody Sales Quantity by Application (2018-2023) & (K Units)
    Table 140. Middle East & Africa VEGFA Antibody Sales Quantity by Application (2024-2029) & (K Units)
    Table 141. Middle East & Africa VEGFA Antibody Sales Quantity by Region (2018-2023) & (K Units)
    Table 142. Middle East & Africa VEGFA Antibody Sales Quantity by Region (2024-2029) & (K Units)
    Table 143. Middle East & Africa VEGFA Antibody Consumption Value by Region (2018-2023) & (USD Million)
    Table 144. Middle East & Africa VEGFA Antibody Consumption Value by Region (2024-2029) & (USD Million)
    Table 145. VEGFA Antibody Raw Material
    Table 146. Key Manufacturers of VEGFA Antibody Raw Materials
    Table 147. VEGFA Antibody Typical Distributors
    Table 148. VEGFA Antibody Typical Customers
List of Figures
    Figure 1. VEGFA Antibody Picture
    Figure 2. Global VEGFA Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global VEGFA Antibody Consumption Value Market Share by Type in 2022
    Figure 4. Monoclonal Antibody Examples
    Figure 5. Polyclonal Antibody Examples
    Figure 6. Global VEGFA Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global VEGFA Antibody Consumption Value Market Share by Application in 2022
    Figure 8. Flow Cytometry Examples
    Figure 9. ELISA Examples
    Figure 10. Western Blot Examples
    Figure 11. Immunoprecipitation Examples
    Figure 12. Immunofluorescence Examples
    Figure 13. Others Examples
    Figure 14. Global VEGFA Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global VEGFA Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global VEGFA Antibody Sales Quantity (2018-2029) & (K Units)
    Figure 17. Global VEGFA Antibody Average Price (2018-2029) & (US$/Unit)
    Figure 18. Global VEGFA Antibody Sales Quantity Market Share by Manufacturer in 2022
    Figure 19. Global VEGFA Antibody Consumption Value Market Share by Manufacturer in 2022
    Figure 20. Producer Shipments of VEGFA Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 21. Top 3 VEGFA Antibody Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Top 6 VEGFA Antibody Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Global VEGFA Antibody Sales Quantity Market Share by Region (2018-2029)
    Figure 24. Global VEGFA Antibody Consumption Value Market Share by Region (2018-2029)
    Figure 25. North America VEGFA Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 26. Europe VEGFA Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 27. Asia-Pacific VEGFA Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 28. South America VEGFA Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 29. Middle East & Africa VEGFA Antibody Consumption Value (2018-2029) & (USD Million)
    Figure 30. Global VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 31. Global VEGFA Antibody Consumption Value Market Share by Type (2018-2029)
    Figure 32. Global VEGFA Antibody Average Price by Type (2018-2029) & (US$/Unit)
    Figure 33. Global VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 34. Global VEGFA Antibody Consumption Value Market Share by Application (2018-2029)
    Figure 35. Global VEGFA Antibody Average Price by Application (2018-2029) & (US$/Unit)
    Figure 36. North America VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 37. North America VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 38. North America VEGFA Antibody Sales Quantity Market Share by Country (2018-2029)
    Figure 39. North America VEGFA Antibody Consumption Value Market Share by Country (2018-2029)
    Figure 40. United States VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Canada VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Mexico VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Europe VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 44. Europe VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 45. Europe VEGFA Antibody Sales Quantity Market Share by Country (2018-2029)
    Figure 46. Europe VEGFA Antibody Consumption Value Market Share by Country (2018-2029)
    Figure 47. Germany VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. France VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. United Kingdom VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Russia VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Italy VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Asia-Pacific VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 53. Asia-Pacific VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 54. Asia-Pacific VEGFA Antibody Sales Quantity Market Share by Region (2018-2029)
    Figure 55. Asia-Pacific VEGFA Antibody Consumption Value Market Share by Region (2018-2029)
    Figure 56. China VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Japan VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Korea VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. India VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Southeast Asia VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Australia VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. South America VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 63. South America VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 64. South America VEGFA Antibody Sales Quantity Market Share by Country (2018-2029)
    Figure 65. South America VEGFA Antibody Consumption Value Market Share by Country (2018-2029)
    Figure 66. Brazil VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Argentina VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Middle East & Africa VEGFA Antibody Sales Quantity Market Share by Type (2018-2029)
    Figure 69. Middle East & Africa VEGFA Antibody Sales Quantity Market Share by Application (2018-2029)
    Figure 70. Middle East & Africa VEGFA Antibody Sales Quantity Market Share by Region (2018-2029)
    Figure 71. Middle East & Africa VEGFA Antibody Consumption Value Market Share by Region (2018-2029)
    Figure 72. Turkey VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Egypt VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Saudi Arabia VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. South Africa VEGFA Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. VEGFA Antibody Market Drivers
    Figure 77. VEGFA Antibody Market Restraints
    Figure 78. VEGFA Antibody Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of VEGFA Antibody in 2022
    Figure 81. Manufacturing Process Analysis of VEGFA Antibody
    Figure 82. VEGFA Antibody Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sino Biological, Inc.
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
BioLegend
LifeSpan BioSciences, Inc
Elabscience Biotechnology Inc.
Boster Biological Technology
Merck
Wuhan Fine Biotech Co., Ltd.
ProSci Incorporated
Abbexa
Miltenyi Biotec
Arigo Biolaboratories Corp.
Assay Genie

Related Reports

Global VEGFA Antibody Supply, Demand and Key Producers, 2023-2029

Global VEGFA Antibody Supply, Demand and Key Producers, 2023-2029

date 02 Sep 2023

date Pharma & Healthcare

The global VEGFA Antibody market size is expected to reach $ 890.1 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).

Global VEGFA Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global VEGFA Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global VEGFA Antibody market size was valued at USD 406 million in 2023 and is forecast to a readjusted size of USD 890.1 million by 2030 with a CAGR of 11.9% during review period.

Global VEGFA Antibody Supply, Demand and Key Producers, 2024-2030

Global VEGFA Antibody Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global VEGFA Antibody market size is expected to reach $ 890.1 million by 2030, rising at a market growth of 11.9% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>